EGFR and triple-negative breast carcinoma: In addition, increased expression and/or gene amplification of EGFR have been observed in many human cancers, including triple negative breast cancer MDA-MB-231 cells, and has been associated to increased cell proliferation and motility, disease progression and poor prognosis25,26.